Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

Companies have been battling with a lack of private investment in recent years but could now face a lack of government funds.

Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing symptoms by 50%.

Strategic transformation ongoing, positioning the Company as a focused leader in immunology and inflammatory diseasesHighly differentiated, ...

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia and obesity. Rhythm is evaluating setmelanotide in a global Phase 3 trial in patients with acquired hypothalamic ...

Weekly subcutaneous administration of sabirnetug was well-tolerated in the Phase 1 study Systemic exposure following subcutaneous administration ...

The US joins Moldova, Hong Kong, and New Zealand as countries to greenlight the company's Phase I trial of PBGENE-HBV.

A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; p=0.003 vs. placebo) on the primary outcome measure, change ...

Two criminals involved in a Hatton Garden money laundering scheme have been jailed after attempting to smuggle £190million worth of drugs into the UK and wash the proceeds through London's iconic ...

BioXcel said the Phase 3 ... The trial's topline-data results, which are expected in the second half of 2025, are intended to support a potential supplemental new drug application submission ...

David Walters, NPAS Head of Futures and Innovation, said the aim of the trial was to determine if advancements in aviation technology can bring future benefits to policing and, if they can, how they ...